Scientists have identified how and why some COVID-19 patients can develop life-threatening clots, which could lead to targeted therapies that prevent this from happening.
10 hours ago
0
8
In Rhode Island, when pregnant women are ready to deliver their babies, 80% of them check in at Women & Infants in Providence, making it one of the largest obstetrical care hospitals in the country. If kids need urgent care, ...
Jun 11, 2021
0
1
In the first and largest global metabolomic study of African children before and after malaria infection, NYU Abu Dhabi Assistant Professor of Biology Youssef Idaghdour and his colleagues at the Centre National de Recherche ...
Jun 10, 2021
0
13
For over a century, researchers have known about "the bends", a serious condition affecting scuba divers. However, we still know relatively little about its physiological basis. Doctors do not yet have a definitive test for ...
Jun 10, 2021
0
10
A new lifesaving treatment for people suffering from vaccine-related blood clots has been demonstrated by scientists at McMaster University.
Jun 09, 2021
0
9
New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new therapeutic anti-viral target. The research also found the presence of detectable ...
Jun 07, 2021
0
14
One challenge as society reopens is identifying who has been vaccinated for SARS-CoV-2, the virus that causes COVID-19. A team of Johns Hopkins researchers has developed a rapid blood test that could confirm a person has ...
Jun 04, 2021
0
50
The risk of being infected with SARS-CoV-2, the virus that causes COVID-19, is substantially reduced for up to 10 months following a first infection, according to new findings from the Vivaldi study led by UCL researchers.
Jun 03, 2021
4
22
A University of Birmingham-led study of over a thousand dental professionals has shown their increased occupational risk of SARS-CoV-2 infection during the first wave of the pandemic in the UK.
Jun 03, 2021
0
5
The National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of different COVID-19 vaccines to determine the ...
Jun 02, 2021
0
1
